Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Liabilities from Discontinued Operations (2017)

Historic Liabilities from Discontinued Operations for Fortress Biotech (FBIO) over the last 1 years, with Q4 2017 value amounting to $29.3 million.

  • Fortress Biotech's Liabilities from Discontinued Operations changed N/A to $29.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was $29.3 million, marking a year-over-year change of. This contributed to the annual value of $29.3 million for FY2017, which is N/A changed from last year.
  • Per Fortress Biotech's latest filing, its Liabilities from Discontinued Operations stood at $29.3 million for Q4 2017.
  • Fortress Biotech's 5-year Liabilities from Discontinued Operations high stood at $29.3 million for Q4 2017, and its period low was $29.3 million during Q4 2017.